ID   DDAH1_HUMAN             Reviewed;         285 AA.
AC   O94760; Q5HYC8; Q86XK5;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   15-MAR-2017, entry version 156.
DE   RecName: Full=N(G),N(G)-dimethylarginine dimethylaminohydrolase 1;
DE            Short=DDAH-1;
DE            Short=Dimethylarginine dimethylaminohydrolase 1;
DE            EC=3.5.3.18;
DE   AltName: Full=DDAHI;
DE   AltName: Full=Dimethylargininase-1;
GN   Name=DDAH1; Synonyms=DDAH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 2-12 AND
RP   35-50, ABSENCE OF BOUND ZINC, AND ACETYLATION AT ALA-2.
RC   TISSUE=Kidney, and Liver;
RX   PubMed=9874257; DOI=10.1046/j.1432-1327.1998.2580863.x;
RA   Kimoto M., Miyatake S., Sasagawa T., Yamashita H., Okita M., Oka T.,
RA   Ogawa T., Tsuji H.;
RT   "Purification, cDNA cloning and expression of human NG,NG-
RT   dimethylarginine dimethylaminohydrolase.";
RL   Eur. J. Biochem. 258:863-868(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=10493931; DOI=10.1042/bj3430209;
RA   Leiper J.M., Santa Maria J., Chubb A., MacAllister R.J., Charles I.G.,
RA   Whitley G.S., Vallance P.;
RT   "Identification of two human dimethylarginine dimethylaminohydrolases
RT   with distinct tissue distributions and homology with microbial
RT   arginine deiminases.";
RL   Biochem. J. 343:209-214(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Endometrial cancer;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon, Kidney, Stomach, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 20-31; 46-57; 112-136; 150-196; 212-230 AND
RP   268-281, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   CATALYTIC ACTIVITY, ENZYME REGULATION, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=18171027; DOI=10.1021/bi701659n;
RA   Forbes S.P., Druhan L.J., Guzman J.E., Parinandi N., Zhang L.,
RA   Green-Church K.B., Cardounel A.J.;
RT   "Mechanism of 4-HNE mediated inhibition of hDDAH-1: implications in NO
RT   regulation.";
RL   Biochemistry 47:1819-1826(2008).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 2-284 IN COMPLEXES WITH
RP   CITRULLINE AND INHIBITOR L-257.
RX   PubMed=17273169; DOI=10.1038/nm1543;
RA   Leiper J., Nandi M., Torondel B., Murray-Rust J., Malaki M.,
RA   O'Hara B., Rossiter S., Anthony S., Madhani M., Selwood D., Smith C.,
RA   Wojciak-Stothard B., Rudiger A., Stidwill R., McDonald N.Q.,
RA   Vallance P.;
RT   "Disruption of methylarginine metabolism impairs vascular
RT   homeostasis.";
RL   Nat. Med. 13:198-203(2007).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEX WITH
RP   N-1-IMINOPROPYL-L-ORNITHINE, CATALYTIC ACTIVITY, ZINC-BINDING, ENZYME
RP   REGULATION, SUBUNIT, BIOPHYSICOCHEMICAL PROPERTIES, ACTIVE SITE,
RP   MUTAGENESIS OF LEU-30; GLU-78 AND LEU-271, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=19663506; DOI=10.1021/bi9007098;
RA   Wang Y., Monzingo A.F., Hu S., Schaller T.H., Robertus J.D., Fast W.;
RT   "Developing dual and specific inhibitors of dimethylarginine
RT   dimethylaminohydrolase-1 and nitric oxide synthase: toward a targeted
RT   polypharmacology to control nitric oxide.";
RL   Biochemistry 48:8624-8635(2009).
CC   -!- FUNCTION: Hydrolyzes N(G),N(G)-dimethyl-L-arginine (ADMA) and
CC       N(G)-monomethyl-L-arginine (MMA) which act as inhibitors of NOS.
CC       Has therefore a role in the regulation of nitric oxide generation.
CC   -!- CATALYTIC ACTIVITY: N(omega),N(omega)-dimethyl-L-arginine + H(2)O
CC       = dimethylamine + L-citrulline. {ECO:0000269|PubMed:18171027,
CC       ECO:0000269|PubMed:19663506}.
CC   -!- ENZYME REGULATION: Inhibited by zinc ions (By similarity). Enzyme
CC       purified in the absence of 1,10-phenanthroline contains on average
CC       0.4 zinc atoms per subunit. Inhibited by 4-hydroxy-nonenal through
CC       the formation of a covalent adduct with His-173. Competitively
CC       inhibited by N(5)-iminopropyl-ornithine. {ECO:0000250,
CC       ECO:0000269|PubMed:18171027, ECO:0000269|PubMed:19663506}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=69 uM for asymmetric dimethylarginine (ADMA)
CC         {ECO:0000269|PubMed:18171027, ECO:0000269|PubMed:19663506};
CC         KM=54 uM for monomethyl-L-arginine (MMA)
CC         {ECO:0000269|PubMed:18171027, ECO:0000269|PubMed:19663506};
CC         KM=3.1 uM for S-methyl-L-thiocitrulline
CC         {ECO:0000269|PubMed:18171027, ECO:0000269|PubMed:19663506};
CC         Vmax=356 nmol/min/mg enzyme with ADMA
CC         {ECO:0000269|PubMed:18171027, ECO:0000269|PubMed:19663506};
CC         Vmax=154 nmol/min/mg enzyme with NMA
CC         {ECO:0000269|PubMed:18171027, ECO:0000269|PubMed:19663506};
CC       pH dependence:
CC         Optimum pH is 8.5. {ECO:0000269|PubMed:18171027,
CC         ECO:0000269|PubMed:19663506};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:19663506}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O94760-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O94760-2; Sequence=VSP_043813;
CC   -!- TISSUE SPECIFICITY: Detected in brain, liver, kidney and pancreas,
CC       and at low levels in skeletal muscle.
CC       {ECO:0000269|PubMed:10493931}.
CC   -!- SIMILARITY: Belongs to the DDAH family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB001915; BAA37117.1; -; mRNA.
DR   EMBL; BX648145; CAI45988.1; -; mRNA.
DR   EMBL; AC092807; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL078459; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL360219; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471097; EAW73199.1; -; Genomic_DNA.
DR   EMBL; BC033680; AAH33680.1; -; mRNA.
DR   EMBL; BC043235; AAH43235.2; -; mRNA.
DR   CCDS; CCDS44170.1; -. [O94760-2]
DR   CCDS; CCDS705.1; -. [O94760-1]
DR   RefSeq; NP_001127917.1; NM_001134445.1. [O94760-2]
DR   RefSeq; NP_036269.1; NM_012137.3. [O94760-1]
DR   RefSeq; XP_005270767.1; XM_005270710.2. [O94760-2]
DR   UniGene; Hs.713411; -.
DR   PDB; 2JAI; X-ray; 2.30 A; A/B=2-285.
DR   PDB; 2JAJ; X-ray; 2.00 A; A/B=2-285.
DR   PDB; 3I2E; X-ray; 2.03 A; A/B=1-285.
DR   PDB; 3I4A; X-ray; 1.90 A; A/B=1-285.
DR   PDB; 3P8E; X-ray; 2.49 A; A/B=1-285.
DR   PDB; 3P8P; X-ray; 2.50 A; A/B=1-285.
DR   PDBsum; 2JAI; -.
DR   PDBsum; 2JAJ; -.
DR   PDBsum; 3I2E; -.
DR   PDBsum; 3I4A; -.
DR   PDBsum; 3P8E; -.
DR   PDBsum; 3P8P; -.
DR   ProteinModelPortal; O94760; -.
DR   SMR; O94760; -.
DR   BioGrid; 117114; 14.
DR   DIP; DIP-61582N; -.
DR   IntAct; O94760; 2.
DR   STRING; 9606.ENSP00000284031; -.
DR   BindingDB; O94760; -.
DR   ChEMBL; CHEMBL6036; -.
DR   DrugBank; DB00155; L-Citrulline.
DR   GuidetoPHARMACOLOGY; 1247; -.
DR   iPTMnet; O94760; -.
DR   PhosphoSitePlus; O94760; -.
DR   SwissPalm; O94760; -.
DR   BioMuta; DDAH1; -.
DR   REPRODUCTION-2DPAGE; IPI00220342; -.
DR   EPD; O94760; -.
DR   MaxQB; O94760; -.
DR   PaxDb; O94760; -.
DR   PeptideAtlas; O94760; -.
DR   PRIDE; O94760; -.
DR   Ensembl; ENST00000284031; ENSP00000284031; ENSG00000153904. [O94760-1]
DR   Ensembl; ENST00000426972; ENSP00000411189; ENSG00000153904. [O94760-2]
DR   Ensembl; ENST00000535924; ENSP00000439045; ENSG00000153904. [O94760-2]
DR   Ensembl; ENST00000539042; ENSP00000438604; ENSG00000153904. [O94760-1]
DR   GeneID; 23576; -.
DR   KEGG; hsa:23576; -.
DR   UCSC; uc001dlb.4; human. [O94760-1]
DR   CTD; 23576; -.
DR   DisGeNET; 23576; -.
DR   GeneCards; DDAH1; -.
DR   HGNC; HGNC:2715; DDAH1.
DR   HPA; HPA006308; -.
DR   MIM; 604743; gene.
DR   neXtProt; NX_O94760; -.
DR   OpenTargets; ENSG00000153904; -.
DR   PharmGKB; PA27185; -.
DR   eggNOG; ENOG410IFS6; Eukaryota.
DR   eggNOG; COG1834; LUCA.
DR   GeneTree; ENSGT00390000009331; -.
DR   HOGENOM; HOG000161035; -.
DR   HOVERGEN; HBG055937; -.
DR   InParanoid; O94760; -.
DR   KO; K01482; -.
DR   OMA; CNGIALI; -.
DR   OrthoDB; EOG091G0M5S; -.
DR   PhylomeDB; O94760; -.
DR   TreeFam; TF314737; -.
DR   BRENDA; 3.5.3.18; 2681.
DR   Reactome; R-HSA-203615; eNOS activation.
DR   ChiTaRS; DDAH1; human.
DR   EvolutionaryTrace; O94760; -.
DR   GenomeRNAi; 23576; -.
DR   PRO; PR:O94760; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000153904; -.
DR   CleanEx; HS_DDAH1; -.
DR   ExpressionAtlas; O94760; baseline and differential.
DR   Genevisible; O94760; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0016597; F:amino acid binding; IEA:Ensembl.
DR   GO; GO:0003824; F:catalytic activity; TAS:ProtInc.
DR   GO; GO:0016403; F:dimethylargininase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006527; P:arginine catabolic process; TAS:ProtInc.
DR   GO; GO:0000052; P:citrulline metabolic process; IDA:UniProtKB.
DR   GO; GO:0007263; P:nitric oxide mediated signal transduction; TAS:ProtInc.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; ISS:BHF-UCL.
DR   GO; GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome.
DR   GO; GO:0003073; P:regulation of systemic arterial blood pressure; ISS:BHF-UCL.
DR   InterPro; IPR033199; DDAH/AD.
DR   InterPro; IPR033197; DDAH1.
DR   PANTHER; PTHR12737; PTHR12737; 1.
DR   PANTHER; PTHR12737:SF25; PTHR12737:SF25; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Hydrolase; Metal-binding;
KW   Reference proteome; S-nitrosylation; Zinc.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|PubMed:9874257}.
FT   CHAIN         2    285       N(G),N(G)-dimethylarginine
FT                                dimethylaminohydrolase 1.
FT                                /FTId=PRO_0000171118.
FT   REGION       78     79       Substrate binding.
FT   ACT_SITE    173    173       Proton donor.
FT                                {ECO:0000305|PubMed:19663506}.
FT   ACT_SITE    274    274       Nucleophile.
FT                                {ECO:0000269|PubMed:19663506}.
FT   METAL       274    274       Zinc. {ECO:0000250}.
FT   BINDING      30     30       Substrate; via carbonyl oxygen.
FT   BINDING      73     73       Substrate.
FT   BINDING      98     98       Substrate.
FT   BINDING     145    145       Substrate.
FT   BINDING     268    268       Substrate; via carbonyl oxygen.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|PubMed:9874257}.
FT   MOD_RES     222    222       S-nitrosocysteine.
FT                                {ECO:0000250|UniProtKB:P56965}.
FT   MOD_RES     274    274       S-nitrosocysteine.
FT                                {ECO:0000250|UniProtKB:P56965}.
FT   VAR_SEQ       1    103       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_043813.
FT   MUTAGEN      30     30       L->A: Reduces enzyme activity and
FT                                affinity for asymmetric dimethylarginine
FT                                about 12-fold.
FT                                {ECO:0000269|PubMed:19663506}.
FT   MUTAGEN      78     78       E->A: Reduces enzyme activity about 1000-
FT                                fold, and affinity for asymmetric
FT                                dimethylarginine about 100-fold.
FT                                {ECO:0000269|PubMed:19663506}.
FT   MUTAGEN     271    271       L->G: Reduces enzyme activity about 10-
FT                                fold, and affinity for asymmetric
FT                                dimethylarginine about 7-fold.
FT                                {ECO:0000269|PubMed:19663506}.
FT   STRAND       14     19       {ECO:0000244|PDB:3I4A}.
FT   HELIX        25     28       {ECO:0000244|PDB:3I4A}.
FT   HELIX        40     55       {ECO:0000244|PDB:3I4A}.
FT   TURN         56     58       {ECO:0000244|PDB:3I4A}.
FT   STRAND       61     65       {ECO:0000244|PDB:3I4A}.
FT   TURN         72     75       {ECO:0000244|PDB:3I4A}.
FT   HELIX        77     80       {ECO:0000244|PDB:3I4A}.
FT   STRAND       81     84       {ECO:0000244|PDB:3I4A}.
FT   STRAND       87     90       {ECO:0000244|PDB:3I4A}.
FT   HELIX        96    101       {ECO:0000244|PDB:3I4A}.
FT   HELIX       102    110       {ECO:0000244|PDB:3I4A}.
FT   TURN        111    113       {ECO:0000244|PDB:3I4A}.
FT   STRAND      115    118       {ECO:0000244|PDB:3I4A}.
FT   HELIX       128    130       {ECO:0000244|PDB:3I4A}.
FT   STRAND      131    133       {ECO:0000244|PDB:3I4A}.
FT   STRAND      138    145       {ECO:0000244|PDB:3I4A}.
FT   HELIX       148    157       {ECO:0000244|PDB:3I4A}.
FT   TURN        158    160       {ECO:0000244|PDB:3I4A}.
FT   STRAND      163    167       {ECO:0000244|PDB:3I4A}.
FT   HELIX       174    176       {ECO:0000244|PDB:3I4A}.
FT   STRAND      177    182       {ECO:0000244|PDB:3I4A}.
FT   STRAND      185    189       {ECO:0000244|PDB:3I4A}.
FT   HELIX       192    203       {ECO:0000244|PDB:3I4A}.
FT   STRAND      205    207       {ECO:0000244|PDB:3I2E}.
FT   STRAND      210    216       {ECO:0000244|PDB:3I4A}.
FT   HELIX       217    220       {ECO:0000244|PDB:3I4A}.
FT   STRAND      223    227       {ECO:0000244|PDB:3I4A}.
FT   TURN        228    230       {ECO:0000244|PDB:3I4A}.
FT   STRAND      231    237       {ECO:0000244|PDB:3I4A}.
FT   TURN        239    241       {ECO:0000244|PDB:3I4A}.
FT   HELIX       243    251       {ECO:0000244|PDB:3I4A}.
FT   STRAND      255    260       {ECO:0000244|PDB:3I4A}.
FT   HELIX       263    266       {ECO:0000244|PDB:3I4A}.
FT   TURN        267    269       {ECO:0000244|PDB:3I4A}.
FT   HELIX       273    275       {ECO:0000244|PDB:3I4A}.
FT   STRAND      277    279       {ECO:0000244|PDB:3I4A}.
SQ   SEQUENCE   285 AA;  31122 MW;  CD8875DF267EF39B CRC64;
     MAGLGHPAAF GRATHAVVRA LPESLGQHAL RSAKGEEVDV ARAERQHQLY VGVLGSKLGL
     QVVELPADES LPDCVFVEDV AVVCEETALI TRPGAPSRRK EVDMMKEALE KLQLNIVEMK
     DENATLDGGD VLFTGREFFV GLSKRTNQRG AEILADTFKD YAVSTVPVAD GLHLKSFCSM
     AGPNLIAIGS SESAQKALKI MQQMSDHRYD KLTVPDDIAA NCIYLNIPNK GHVLLHRTPE
     EYPESAKVYE KLKDHMLIPV SMSELEKVDG LLTCCSVLIN KKVDS
//
